Case of Tamiflu-resistant H1N1 flu identified

By
September 10, 2009 13:02

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

An H1N1 flu patient who has completely recovered was identified at the Health Ministry's central virus lab as having a strain resistant to treatment by Tamiflu, the antiviral drug that is being prescribed to high-risk H1N1 patients. The same has happened in other countries around the world. The ministry said Thursday that it was continuing to study the resistant strain and its significance, but was not changing its policy on dealing with the H1N1 flu.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

Breaking news
October 22, 2018
Some 2,000 Palestinians demonstrate by the Gaza border

By JERUSALEM POST STAFF